Donley Matthew Maxwell has filed 13 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 40761 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 40761 | $14.21 | 680,299.0000 | 138,959,000 | 5.65% | 0.03% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 58160 | $0.00 | 721,060.0000 | 138,959,000 | 8.77% | 0.04% |
| Feb. 27, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Employee Stock Option (right to buy) | 97256 | $0.00 | 97,256.0000 | 138,959,000 | 9999.99% | 0.07% |
| Feb. 20, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 32901 | $14.40 | 662,900.0000 | 138,959,000 | 4.73% | 0.02% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 54166 | $0.00 | 734,631.0000 | 138,959,000 | 7.96% | 0.04% |
| Jan. 2, 2026 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | F | Common Stock | 42787 | $15.95 | 695,801.0000 | 138,959,000 | 5.79% | 0.03% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 82781 | $0.00 | 669,791.0000 | 146,194,000 | 14.10% | 0.06% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Common Stock | 135567 | $0.00 | 805,358.0000 | 146,194,000 | 20.24% | 0.09% |
| March 3, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | S | Common Stock | 65902 | $8.00 | 739,456.0000 | 146,194,000 | 8.18% | 0.05% |
| March 4, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | S | Common Stock | 58991 | $7.92 | 680,465.0000 | 146,194,000 | 7.98% | 0.04% |
| Feb. 28, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | Chief Operating Officer | A | Employee Stock Option (right to buy) | 126416 | $0.00 | 126,416.0000 | 146,194,000 | 9999.99% | 0.09% |
| March 6, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | EVP, Ops & Strategy | S | Common Stock | 40665 | $5.51 | 584,072.0000 | 143,236,000 | 6.51% | 0.03% |
| Feb. 20, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Donley Matthew Maxwell | EVP, Ops & Strategy | A | Common Stock | 216666 | $0.00 | 624,737.0000 | 143,236,000 | 53.10% | 0.15% |